PsyBio Therapeutics Corp V.PSYB.H

$ORIG worth keeping an eye on

[partystocker]

With public acceptance of therapeutic psychedelics increasing, there are a few companies on my radar to watch in the immediate future. With business publications starting to hop on the trend now, it’s only a matter of time before we start to see an uptick in the psychedelics market overall.

One of the Canadian players I’m keeping an eye on right now is psychedelic fund Origin Therapeutics. Origin Therapeutics is expected to IPO before the end of the quarter under the ticker $ORIG. 

Origin announced their official leadership team earlier this month, and it looks like they’ve assembled a strong group. I’m excited to see how $ORIG will perform, as I think they offer a unique portfolio that offers some great exposure to private companies in the psychedelics field.

With $ORIG’s recently IPO’d investee TripSitter positioned to potentially see a swing in prices, it’s a great time to keep an eye on the company right now.

https://www.bcbusiness.ca/BCs-functional-and-psychedelic-mushroom-industry-is-having-a-shroom-boom